Business Context and Reporting Period
This Form 8-K is filed by Manhattan Pharmaceuticals, Inc. (noted as TG THERAPEUTICS, INC. in metadata) for the reporting period of January 8, 2007. The filing addresses a notice received from the American Stock Exchange (Amex) regarding the Company's failure to meet continued listing standards.
Key Financial Metrics
The filing does not provide specific revenue, profit, cash flow, or debt figures. However, it cites the following financial conditions as the basis for the listing notice:
- Stockholders' Equity: Less than $4,000,000 as of September 30, 2006.
- Profitability: The Company reported losses from continuing operations and/or net losses in three of its four most recent fiscal years.
- Historical Performance: The Company has stockholders' equity of less than $6,000,000 and losses in its five most recent fiscal years.
Material Changes and Listing Status
On January 8, 2007, the Company received an "Amex Notice" indicating non-compliance with Section 1003(a)(ii) and Section 1003(a)(iii) of the Amex Company Guide. This notice triggers a requirement to submit a compliance plan to the Amex by February 7, 2007. The plan must detail actions to achieve compliance by April 16, 2008. Failure to submit an acceptable plan or to make progress under an accepted plan may result in delisting proceedings.
Outlook, Risks, and Management Commentary
Management intends to submit a compliance plan by the February 7, 2007 deadline. The Company expects its common stock to continue trading on the Amex without interruption while the plan is under review. However, the filing explicitly states there can be no assurance that the plan will be accepted or that the Company will successfully meet the progress requirements. The primary risk is the potential delisting of the Company's stock if compliance is not achieved by April 16, 2008.
Investor Verification Checklist
- Verify the exact date and content of the compliance plan submission to the Amex (due February 7, 2007).
- Monitor the Amex's decision on whether to accept the Company's compliance plan.
- Review subsequent filings for updates on the Company's stockholders' equity and profitability status leading up to the April 16, 2008 deadline.
- Confirm the trading status of the stock on the Amex to ensure no interruption has occurred.